Cargando…

ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease

Moyamoya disease is a rare condition that is primarily reported in Asian populations, characterized by stenoocclusive intracranial angiopathy with small, fragile, and multiple collateral vessel formation. Extracranial complications, mainly abnormalities within the renal vasculature, have been descri...

Descripción completa

Detalles Bibliográficos
Autores principales: Livesay, James, Johnson, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378792/
https://www.ncbi.nlm.nih.gov/pubmed/30863645
http://dx.doi.org/10.1155/2019/7124072
_version_ 1783395990686924800
author Livesay, James
Johnson, Jeffrey
author_facet Livesay, James
Johnson, Jeffrey
author_sort Livesay, James
collection PubMed
description Moyamoya disease is a rare condition that is primarily reported in Asian populations, characterized by stenoocclusive intracranial angiopathy with small, fragile, and multiple collateral vessel formation. Extracranial complications, mainly abnormalities within the renal vasculature, have been described; however, there are very few case reports of cardiovascular complications in patients with Moyamoya disease. We report a 26-year-old Caucasian female with known Moyamoya disease who presented with both typical and atypical chest pain, mimicking symptoms of a previous non-ST-elevation myocardial infarction. Approximately six months prior to the current hospital admission, she underwent coronary angiography requiring percutaneous coronary intervention (PCI) with two drug-eluting stents to the right coronary artery (RCA) for a critical stenosis. Despite medical management, our patient developed inferior lead ST-elevations leading to a repeat left heart catheterization which showed clinically significant stenosis of the first obtuse marginal branch. Development of significant coronary artery stenosis in a short period of time demonstrates the clinical significance of minimal atherosclerosis in the setting of underlying fibrocellular thickening as seen in patients with Moyamoya disease. Clinicians need to be aware of the possibility of coronary involvement in addition to intracranial vascular complications in patients with Moyamoya disease and take appropriate measures to prevent or delay the development of atherosclerosis in these arteries.
format Online
Article
Text
id pubmed-6378792
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63787922019-03-12 ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease Livesay, James Johnson, Jeffrey Case Rep Cardiol Case Report Moyamoya disease is a rare condition that is primarily reported in Asian populations, characterized by stenoocclusive intracranial angiopathy with small, fragile, and multiple collateral vessel formation. Extracranial complications, mainly abnormalities within the renal vasculature, have been described; however, there are very few case reports of cardiovascular complications in patients with Moyamoya disease. We report a 26-year-old Caucasian female with known Moyamoya disease who presented with both typical and atypical chest pain, mimicking symptoms of a previous non-ST-elevation myocardial infarction. Approximately six months prior to the current hospital admission, she underwent coronary angiography requiring percutaneous coronary intervention (PCI) with two drug-eluting stents to the right coronary artery (RCA) for a critical stenosis. Despite medical management, our patient developed inferior lead ST-elevations leading to a repeat left heart catheterization which showed clinically significant stenosis of the first obtuse marginal branch. Development of significant coronary artery stenosis in a short period of time demonstrates the clinical significance of minimal atherosclerosis in the setting of underlying fibrocellular thickening as seen in patients with Moyamoya disease. Clinicians need to be aware of the possibility of coronary involvement in addition to intracranial vascular complications in patients with Moyamoya disease and take appropriate measures to prevent or delay the development of atherosclerosis in these arteries. Hindawi 2019-02-04 /pmc/articles/PMC6378792/ /pubmed/30863645 http://dx.doi.org/10.1155/2019/7124072 Text en Copyright © 2019 James Livesay and Jeffrey Johnson. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Livesay, James
Johnson, Jeffrey
ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
title ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
title_full ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
title_fullStr ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
title_full_unstemmed ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
title_short ST-Elevation Myocardial Infarction (STEMI) in a Patient with Moyamoya Disease
title_sort st-elevation myocardial infarction (stemi) in a patient with moyamoya disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378792/
https://www.ncbi.nlm.nih.gov/pubmed/30863645
http://dx.doi.org/10.1155/2019/7124072
work_keys_str_mv AT livesayjames stelevationmyocardialinfarctionstemiinapatientwithmoyamoyadisease
AT johnsonjeffrey stelevationmyocardialinfarctionstemiinapatientwithmoyamoyadisease